These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 426525)

  • 1. Immunologic features of chronic granulomatous mucocutaneous candidiasis before and after treatment with transfer factor.
    Horsmanheimo M; Krohn K; Virolainen M; Blomqvist K
    Arch Dermatol; 1979 Feb; 115(2):180-4. PubMed ID: 426525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of transfer factor on lymphocyte function in anergic patients.
    Kirkpatrick CH; Rich RR; Smith TK
    J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer factor as an approach to the treatment of immune deficiency disease.
    Schulkind ML; Ayoub EM
    Birth Defects Orig Artic Ser; 1975; 11(1):436-40. PubMed ID: 1096988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of cell-mediated immune responses with transfer factor.
    Kirkpatrick CH
    Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of transfer factor in patients with depressed cellular immunity and chronic infection.
    Rocklin RE
    Birth Defects Orig Artic Ser; 1975; 11(1):431-5. PubMed ID: 1096987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer factor in the treatment of chronic mucocutaneous candidiasis: a controlled study.
    Mobacken H; Hanson LA; Lindholm L; Ljunggren C
    Acta Derm Venereol; 1980; 60(1):51-5. PubMed ID: 6153834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic mucocutaneous candidiasis accompanied by enhanced antibody production.
    Takeya K; Nomoto K; Matsumoto T; Miyake T; Himeno K
    Clin Exp Immunol; 1976 Sep; 25(3):497-500. PubMed ID: 786522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis.
    Fischer A; Ballet JJ; Griscelli C
    J Clin Invest; 1978 Nov; 62(5):1005-13. PubMed ID: 361754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of defective cellular immunity with foetal thymus and dialysable transfer factor. Long-term studies in a patient with chronic mucocutaneous candidiasis.
    Kirkpatrick CH; Ottenson EA; Smith TK; Wells SA; Burdick JF
    Clin Exp Immunol; 1976 Mar; 23(3):414-28. PubMed ID: 947642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological features in a case of chronic granulomatous candidiasis and its treatment with transfer factor.
    Valdimarsson H; Wood CB; Hobbs JR; Holt PJ
    Clin Exp Immunol; 1972 Jun; 11(2):151-63. PubMed ID: 4557179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic mucocutaneous candidiasis. Immunologic evaluation and therapy.
    South MA
    Cutis; 1977 Mar; 19(3):275, 279, 281, 283. PubMed ID: 844330
    [No Abstract]   [Full Text] [Related]  

  • 12. [Transfer factor treatment of chronic mucocutaneous candidiasis].
    Karmazsin L; Oláh E; Szegedi G
    Acta Paediatr Acad Sci Hung; 1976; 17(3):183-91. PubMed ID: 1027316
    [No Abstract]   [Full Text] [Related]  

  • 13. Transfer factor II: results of therapy.
    Spitler LE; Levin AS; Fudenberg HH
    Birth Defects Orig Artic Ser; 1975; 11(1):449-56. PubMed ID: 1096990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and immunological improvement in a patient with chronic mucocutaneous candidiasis treated with transfer factor.
    Businco L; Aiuti F; Franchi F; Frati C; Cavalieri R; Rezza E
    Allergol Immunopathol (Madr); 1976; 4(5):345-50. PubMed ID: 1087530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic mucocutaneous candida mycosis (CMCC) caused by a T-cell defect].
    Rytter M; Schönborn C; Lohrisch I; Haustein UF
    Z Gesamte Inn Med; 1986 Apr; 41(7):214-6. PubMed ID: 3521108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic mucocutaneous moniliasis by immunologic reconstitution.
    Kirkpatrick CH; Rich RR; Graw RG; Smith TK; Mickenberg I; Rogentine GN
    Clin Exp Immunol; 1971 Dec; 9(6):733-48. PubMed ID: 4945734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [First experience with transfer factor therapy in chronic mucocutaneous candida mycosis].
    Westphal HJ; Kaben U; Schröder I; Jenssen HL; Köhler H; Werner H; Mix E
    Dermatol Monatsschr; 1976 Feb; 162(2):124-8. PubMed ID: 955186
    [No Abstract]   [Full Text] [Related]  

  • 18. Modification of an experimental mouse Candida infection by human dialyzable leukocyte extract.
    Sen P; Smith JK; Buse M; Hsieh HC; Lavenhar MA; Lintz D; Louria DB
    Sabouraudia; 1982 Jun; 20(2):85-93. PubMed ID: 7051369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.
    van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA
    Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic mucocutaneous candidiasis: a model for the investigation of cell mediated immunity.
    Holt PJ; Higgs JM; Munro J; Valdimarsson H
    Br J Clin Pract; 1972 Jul; 26(7):331-6. PubMed ID: 5074179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.